Claudia Becker, PhD

Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Switzerland

Poster(s):

• (051) Dipeptidyl Peptidase-4 Inhibitors and Inflammatory Bowel Disease Risk: Impact of Study Design Differences on Treatment Effect
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST

• (327) Characteristics of a population using anti-glaucoma therapy in the UK CPRD GOLD
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST